These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33202858)

  • 21. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
    Coufal S; Galanova N; Bajer L; Gajdarova Z; Schierova D; Jiraskova Zakostelska Z; Kostovcikova K; Jackova Z; Stehlikova Z; Drastich P; Tlaskalova-Hogenova H; Kverka M
    Cells; 2019 Jul; 8(7):. PubMed ID: 31337064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease.
    Zheng X; Chen F; Zhang Q; Liu Y; You P; Sun S; Lin J; Chen N
    Protein Cell; 2017 Sep; 8(9):686-695. PubMed ID: 28523434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trefoil factors in inflammatory bowel disease.
    Aamann L; Vestergaard EM; Grønbæk H
    World J Gastroenterol; 2014 Mar; 20(12):3223-30. PubMed ID: 24696606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary calprotectin is elevated in patients with active inflammatory bowel disease.
    Majster M; Almer S; Boström EA
    Arch Oral Biol; 2019 Nov; 107():104528. PubMed ID: 31442931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative homogeneity of oral bacterial oral in Crohn's disease compared to ulcerative colitis and its connections with antioxidant defense - preliminary report.
    Szczeklik K; Owczarek D; Cibor D; Cześnikiewicz-Guzik M; Krzyściak P; Krawczyk A; Mach T; Karczewska E; Krzyściak W
    Folia Med Cracov; 2019; 59(1):15-35. PubMed ID: 31180073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases.
    Propst A; Propst T; Herold M; Vogel W; Judmaier G
    Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1031-6. PubMed ID: 8680901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles.
    Facchin S; Digiglio L; D'Incà R; Casarin E; Dassie E; Dettin M; Zamuner A; Buda A; De Boni M; Della Libera D; D'Urso A; Sturniolo GC; Morpurgo M
    Nanomedicine; 2017 Aug; 13(6):2027-2036. PubMed ID: 28428053
    [No Abstract]   [Full Text] [Related]  

  • 32. BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Back IR; Marcon SS; Gaino NM; Vulcano DSB; Dorna MS; Sassaki LY
    Arq Gastroenterol; 2017; 54(2):109-114. PubMed ID: 28198913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
    Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro P; Martins D
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):317-328. PubMed ID: 28276813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of biomarkers in inflammatory bowel disease.
    Egea Valenzuela J; Antón Ródenas G; Sánchez Martínez A
    Med Clin (Barc); 2019 Apr; 152(8):310-316. PubMed ID: 30502302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease.
    Quail MA; Russell RK; Van Limbergen JE; Rogers P; Drummond HE; Wilson DC; Gillett PM
    Inflamm Bowel Dis; 2009 May; 15(5):756-9. PubMed ID: 19107785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Salivary Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis.
    Nijakowski K; Rutkowski R; Eder P; Simon M; Korybalska K; Witowski J; Surdacka A
    Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saliva Interleukin-6 in patients with inflammatory bowel disease.
    Aleksandra Nielsen A; Nederby Nielsen J; Schmedes A; Brandslund I; Hey H
    Scand J Gastroenterol; 2005 Dec; 40(12):1444-8. PubMed ID: 16316893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.